August 1, 2019 PR/Corporate

Jonathan Day Named VP, Commercial Operations, Americas

Seasoned Commercial Leader with Track Record in Life Sciences and Diagnostics SOUTH SAN FRANCISCO, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Jonathan Day as Vice President, Commercial Operations, Americas. Day will be responsible for leading all commercial activities in the Americas, furthering market adoption of Fluidigm products, particularly in the growing scientific community studying the human immune... Read more

August 1, 2019 Lab Top-10 Liq. Handling & Robotics PR/Corporate

Laboratories of all Sizes Can Now Harness the Power of Automation with Beckman Coulter

Anaheim, Calif., Aug. 1, 2019 — Beckman Coulter today announced that at the 71st Annual AACC conference it will showcase its clinical chemistry, immunoassay, hematology, urinalysis and microbiology solutions, configured in the booth to meet the specific needs of any sized laboratory. During the Scientific Meeting & Clinical Lab Expo, Beckman Coulter will demonstrate how laboratories... Read more

July 31, 2019 Microscopy PR/Corporate

MTS Systems to Present at Intellisight 2019 Conference

EDEN PRAIRIE, Minn., July 31, 2019 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC) a leading global supplier of high-performance test systems, motion simulators and sensors, today announced that Dr. Jeffrey Graves, President and CEO, will make a presentation to the investment community at the Intellisight 2019 Conference on Wednesday, August 14, at 8:15 a.m. CT at St.... Read more

July 31, 2019 PR/Corporate

Luminex Corporation Reports Second Quarter 2019 Financial Results And Increase In Quarterly Dividend

AUSTIN, Texas, July 31, 2019 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced financial results for the second quarter 2019. Financial and operating highlights for the quarter include: Second quarter consolidated revenue increased 4% to $83.1 million from $79.6 million in the second quarter 2018. Flow cytometry contributed revenue of approximately $13.2 million, or 16% of... Read more

July 26, 2019 PR/Corporate Product Launch

Roche receives CHMP positive opinion for new Tecentriq-based combination therapy as an initial treatment for most common form of advanced lung cancer

Basel, 26 July 2019 Roche receives CHMP positive opinion for new Tecentriq-based combination therapy as an initial treatment for most common form of advanced lung cancer Decision based on data showing that the Tecentriq plus chemotherapy combination demonstrated a significant overall survival (OS) and progression-free survival (PFS) benefit in the first-line treatment of people with... Read more

July 26, 2019 PR/Corporate

Sarah Hlavinka Elected to Quanterix Board of Directors

ADDS BROAD-BASED EXPERIENCE GROWING AND SCALING MULTI-BILLION-DOLLAR INTERNATIONAL COMPANIES | JULY 26, 2019 Billerica, Mass. – July 26, 2019 — Quanterix Corporation(NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced it has further strengthened its Board of Directors with the election of Sarah Hlavinka by the Company’s shareholders.Hlavinka succeeds Douglas G. Cole, M.D., who did not stand for re-election.... Read more

July 25, 2019 PR/Corporate

Bill W. Colston Named to Fluidigm Board of Directors

Jul 25, 2019 Senior Biotechnology Leader with Broad Expertise in Life Science and Digital Health SOUTH SAN FRANCISCO, Calif., July 25, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Bill W. Colston to the company’s Board of Directors. Colston is President of iCarbonX and has more than 30 years of experience across a range of innovative life... Read more

July 25, 2019 M&A, Partnerships PR/Corporate Process Analytical Instr.

908 Devices poised to modernize upstream bioprocess analytics with a grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

07.25.19 908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, announced it has been awarded a technical project grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). This award will fuel continued development of simple, at-line bioreactor process analytics – a collaboration between 908 Devices, MilliporeSigma, the University of North Carolina at Chapel... Read more